Comparing two antibiotics for hospitalized pneumonia patients
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial compares two antibiotics, azithromycin and doxycycline, when given alongside a standard beta-lactam antibiotic to hospitalized adults with community-acquired pneumonia. It aims to see which combination works better and is safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are admitted to the hospital with community-acquired pneumonia (a lung infection not caught in a hospital)
- You are already receiving a beta-lactam antibiotic (a common type of antibiotic) plus either azithromycin or doxycycline in the emergency room within 12 hours of admission
- You are not pregnant
- You do not have a known allergy or reaction to azithromycin or doxycycline
- You do not have severe pneumonia or a suspected Legionella infection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial compares two antibiotics for older adults hospitalized with pneumonia. It aims to see if amoxicillin alone works as well as amoxicillin combined with clavulanate, which might reduce side effects.
This trial is testing how many days of antibiotics are best for adults with pneumonia who are treated by their regular doctor (not in a hospital). The goal is to find the shortest effective treatment to reduce side effects and antibiotic resistance.
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
This study compares two antibiotics to find which works better in children with pneumonia caused by a bacteria called mycoplasma that may not respond to usual treatments. It helps choose the most effective treatment for this specific infection.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.